Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Medicinal Chemistry & Drug Design | Q&As & Interviews

Interview with Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda

Edited by Tom Cohen | 09 June 2022
Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda, talks about working with regulators and the current regulatory paradigm.
https://www.youtube.com/watch?v=ZdnHZmR7pLA&ab_channel=OxfordGlobalMarketingLtd

Visit our Discovery Portal to learn more about the latest research into drug design, development, and more. If you’d like to register your interest for Oxford Global‘s upcoming conference, Organ Modelling 2023, click here.

Get your weekly dose of industry news?here?and keep up to date with the latest?‘Industry Spotlight’ posts.?For other Discovery content, please visit the?Discovery Content Portal.

Related Resources

Biophysical Tools for the Design and Development of PROTACs

Protein degradation has emerged as a promising new field of therapeutics. What are biophysical tools are employed for the characterisation of these drugs?
Read More

RNA Interference: Looking Back at the 2006 Nobel Prize

Fire and Mello’s research has unlocked a powerful new therapeutic technology: silencing genes with siRNA.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
20/03/24
The Design of Novel Drugs with Generative AI
28/03/24
Generative AI and Large Language Models for Quantitative and Systems Pharmacology